Keywords: bayer, novartis, ms, drug, deal, recently-formed, schering

Bayer and Novartis in MS drug deal

Article | 02 April 2007

Print This

Recently-formed Bayer Schering Pharma, the new Berlin-based health care unit of Germany's Bayer AG, has acquired from Swiss drug major ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in